Clinical Trials › NCT06249438
RecruitingPhase 1
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Sponsored by RenJi Hospital
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 30
Target enrollment
Mar 2024
Start date
Mar 2040
Expected completion
Interventions / Treatments
CD20/BCMA-directed CAR-T cells
Conditions studied
Multiple Sclerosis (MS)
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.